First Time Loading...

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 5.14 USD 0.78%
Updated: Apr 29, 2024

ImmuCell Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ImmuCell Corp
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
ImmuCell Corp
NASDAQ:ICCC
Cash from Financing Activities
$1.8m
CAGR 3-Years
-3%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is ImmuCell Corp's Cash from Financing Activities?
Cash from Financing Activities
1.8m USD

Based on the financial report for Dec 31, 2023, ImmuCell Corp's Cash from Financing Activities amounts to 1.8m USD.

What is ImmuCell Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
14%

Over the last year, the Cash from Financing Activities growth was 58%. The average annual Cash from Financing Activities growth rates for ImmuCell Corp have been -3% over the past three years , 14% over the past five years .